Introducing pharmacogenomic decision support for medication risk assessment in people with polypharmacy

Polypharmacy has been shown to be a source of multiple adverse drug events. Recent studies demonstrated that pharmacogenomic testing may be instrumental in optimizing medication regimen. However, majority of current pharmacogenomic decision support tools provide assessment only of single drug-gene i...

Celý popis

Podrobná bibliografia

Vydané v:	2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) s. 1803 - 1808
Hlavní autori:	Jiazhen Liu, Finkelstein, Joseph
Médium:	Konferenčný príspevok..
Jazyk:	English
Vydavateľské údaje:	IEEE 01.11.2017
Predmet:	Additives adverse drug events Biochemistry decision support Drugs Genetics Inhibitors pharmacogenomics polypharmacy Substrates
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!